Journal Article

Comparing saliva and blood for the detection of mosaic genomic abnormalities that cause syndromic intellectual disability

Lunke, Sebastian, Oertel, Ralph, Francis, David I, Petrovic, Vida, Murali, Krithika, Oliver, Karen L, Burgess, Trent, Wall, Meaghan, Downie, Lilian, Gallacher, Lyndon, Stutterd, Chloe A, Kalitsis, Paul, Ayres, Samantha, Wei, Vivian, Scheffer, Ingrid E, Vasudevan, Anand, Hackett, Anna, Boys, Amber, Dun, Karen, Krzesinski, Emma I, Goel, Himanshu, Amor, David J, Baxter, Anne, Stark, Zornitza, Tan, Tiong Yang

2023

Overview

We aimed to determine whether SNP-microarray genomic testing of saliva had a greater diagnostic yield than blood for pathogenic copy number variants (CNVs). We selected patients who underwent CMA testing of both blood and saliva from 23,289 blood and 21,857 saliva samples. Our cohort comprised 370 individuals who had testing of both, 224 with syndromic intellectual disability (ID) and 146 with isolated ID. Mosaic pathogenic CNVs or aneuploidy were detected in saliva but not in blood in 20/370 (4.4%). All 20 individuals had syndromic ID, accounting for 9.1% of the syndromic ID sub-cohort. Pathogenic CNVs were large in size (median of 46 Mb), and terminal in nature, with median mosaicism of 27.5% (not exceeding 40%). By contrast, non-mosaic pathogenic CNVs were 100% concordant between blood and saliva, considerably smaller in size (median of 0.65 Mb), and predominantly interstitial in location. Given that salivary microarray testing has increased diagnostic utility over blood in individuals with syndromic ID, we recommend it as a first-tier testing in this group.

• Publisher: Nature Publishing Group
• Subject: Aneuploidy / Blood / Copy number / Genomics / Intellectual disabilities / Mosaicism / Saliva